Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-09-002351
Filing Date
2009-01-14
Accepted
2009-01-14 20:46:10
Documents
1
Period of Report
2009-01-12

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 8750
  Complete submission text file 0001104659-09-002351.txt   10744
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 485 UNDERHILL BLVD STE 205 SYOSSET NY 11791-3419
Business Address
KNOTT DAVID M (Reporting) CIK: 0000808722 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 09527384